NEW YORK (GenomeWeb News) – Quest Diagnostics today said that it has sold substantially all of the assets of its OralDNA Labs business to Access Genetics for an undisclosed sum.

The business, which currently provides saliva-based testing from a facility in Tennessee, will be consolidated with Access Genetics' CLIA- and CAP-certified lab in Eden Prairie, Minn. Quest noted that Access Genetics has provided support and expertise for OralDNA-based testing services for dental professionals since 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.